Bharat Biotech set to acquire Chiron Behring Vaccines from GSK
The 100% equity stake of Ankleshwar, Gujarat based Chiron Behring Vaccines which is a part of GlaxoSmithKline Asia will be acquired by Bharat Biotech in an all cash transaction, subject to a number of closing conditions which both the parties intend to complete in the coming weeks